59.Kreiswirth BN，Moss A.Genotyping multidrug resistant M.tuberculosis in New York city.In：Rom WN，Garay SN，eds.Tuberculosis in Boston：Little Brown Company，1996，1199-2091
60.Salfinger M，Heifets LB.Determination of pyrazinamide M ICs for Mycobacterium tuberculosis at different pHs by the radio-metric method.Antimicrob Agents Chemother，1988，32：1002
61.Boshoff H I，Mizrahi V.Purification，gene cloning，targeted knockout，overexp ression，and biochemical characterization of the major pyrazinamidase from Mycobacterium smegmatis.J B acteriol，1998，180（22）：5809
62.Scorpio A，Zhang Y.Mutations in pncA，a gene encoding pyrazinamidase/nicotinamidase，cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus.Nat Med.1996，（6）：662-7.
63.Cheng SJ，Thibert L，Sanchez T，et al.pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis：sp read of a monoresistant strain in Quebec，Canada.Antim icrob Agents Chem other，2000，44：528
64.Miyagi C，Yamane N，Yogesh B，et al.Genetic and phenotypic characterization of pyrazinamide-resistant Mycobacterium tuberculosis comp lex isolates in Japan.Diagn Microbiol Infect Dis，2004，48：111
65.Suzuki Y，Suzuki A，Tamaru A，et al.Rap id detection of pyrazinamide-resistant Mycobacterium tuberculosis by a PCR-Based in vitro system.J Clin M icrobiol，2002，40：501
66.Alangaden GJ，L ermer SA.The clinical use of fluoroquinolones for the treatment of mycobacterial diseases.Clin Infect Dis，1997，25：1213-1221.
67.Takiff HE，Salazar L，Guerrero C，Philipp W，Huang WM，Kreiswirth B，Cole ST，Jacobs WR Jr，Telenti A.Cloning and nucleotide sequece of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quino lone resistance mutations.Antimicrob Agents Chemother，1994，38：773-780.
68.Guille I，Cambau E，Jarlier V.Sequences of conserved region in the A subunit of DNA gyrase from nine species of the genus Mycobacterium：Phylogenetic analysis and implication for intrinsic susceptibility to quinolones.Antimicrob Agents Chemother，1995，39：2145-2149.
69.Guillemin I，Jarlier V ，Cambau E.Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria.Antimicrob Agents Chemother，1998，42（8）：2084-2088.
70.Cabral JM，Jackson AP，Smith CV，Shikotra N，Maxwell A，Liddington RC.Crystal structure of the breakage–reunion domain of DNA gyrase.Nature，1997，388：903-906
71.Onodera Y，TanakaM，Sato K.Inhibitory activity of quinolones against DNA gyrase of Mycrobacterium tuberculosis.J Antimicrob Chemoth，2001，47：447-450.
72.Takiff HE，Cimino M，Musso MC，et al.Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium semegamatis.PNAS，1996，93：362-366.
73.Waiters SB，Hanna BA.Testing of susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin by Mycobacterium growth indicator tube method.J Clin Microbiol，1996，34：1565-1567.
74.Venkataraman P，Herbert D，Paramasivan CN.Evaluation of BACTEC radiometric method in the early diagnosis of tuberculosis.Indian J Med Res，1998，108：120-7.
75.Hanna BA，Ebrahimzadeh A，Elliott LB，et al.Multicenter evaluation of the BACTECMGIT960system for recovery of Mycobacteria.J Clin Microbiol，1999，37：748-752.
76.Pfyffer GE，Kisshug P，Rush-Gerckes S，et al.Rapid detection of Mycobacteria in clinical specimens by using the automated BACTEC 9000MB system and comparison with radiometric and solid-culture systems.J ClinMicrobiol，1997，35：2229-2234.
77.Thorpe TC，Wilson ML，Tumer JE，et al.Bact/Alert：an automated colormetric microbial detection system.J Clin Microbial，1990，28：1608-1612.
78.Woods GL，Fish G，Plauor M，et al.Clincal evaluation of the ESP culture system Ⅱfor growth and detection of Mycobacteia.J Clin Microbiol，1997，35：121-124.
79.Albert H，Heydenrych A，Brooks R，et a1.Performance of a rapid Phage－based test FAST Plaque TBTM，to diagnose pulmonary tuberculosis from sputum specimens in South Africa.Int J Tuberc Lung Dis，2002，6：529-537.
80.Marei AM，Behedy EM，Mohtady HA，et a1.Evaluation of Mycobacterium tuberculosis in clinical Samples.J Med Microbio1，2003，52：331-335.
81.Wilson SM，Suwaid ZL，Mcnemey R，et a1.Evaluation of a new rapid bacteriophage based method for the drug susceptibility testing of Mycebacterium tuberculosis.Nat Med，1997，3：65-468.
82.Eltringham JJ，Wilson SM，Drobniewki FA.Evaluation of a bacteriophage-based assay （Phage amplified biologically assay）as a rapid screen for resistance to Isoniazid，Ethambutol，Streptomycin，pyrazinamide，and ciprofloxacin among clinical isolates of Mycebacterium tuberculosis.J Clin Microbiol，1999，37：3528-3532.
83.Zhang SL，Qi H，Qiu DL，et al.Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates recovered from Central China.Biochem Genet，2007，45，nos 1/2（accepted）
84.Alderborn A，Kristofferson A，Hammerling U.Determination of single-nucleotide polymorphisms by real-time pyrophosphate DNA sequencing.Genome Res.2000，10（8）：1249-58.
85.Ronaghi M，Karamohamed S，Pettersson B，et al.Real-time DNA sequencing using detection of pyrophosphate release.Anal Biochem，1996，242（1）：84-89.
86.Nyren P，Karamohamed S，Ronaghi M.Detection of single base changes using a bioluminometric primer extension assay.Anal Biochem，1997，244（2）：367-373.
87.赵锦荣，白玉杰，王琰，张庆华，罗明，闫小君.高通量测定技术检测结核分枝杆菌耐利福平的研究.中华结核和呼吸杂志，2005，28：297–300.